291 related articles for article (PubMed ID: 22340179)
1. Inflammation in coronary artery diseases.
Li JJ
Chin Med J (Engl); 2011 Nov; 124(21):3568-75. PubMed ID: 22340179
[TBL] [Abstract][Full Text] [Related]
2. The role of monocytes in atherosclerotic coronary artery disease.
Pamukcu B; Lip GY; Devitt A; Griffiths H; Shantsila E
Ann Med; 2010 Sep; 42(6):394-403. PubMed ID: 20568979
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory biomarkers of coronary atheromatous plaque vulnerability.
Avanzas P; Arroyo-Espliguero R; Garcia-Moll X; Kaski JC
Panminerva Med; 2005 Jun; 47(2):81-91. PubMed ID: 16210993
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory markers in coronary artery disease.
Ikonomidis I; Michalakeas CA; Parissis J; Paraskevaidis I; Ntai K; Papadakis I; Anastasiou-Nana M; Lekakis J
Biofactors; 2012; 38(5):320-8. PubMed ID: 22628054
[TBL] [Abstract][Full Text] [Related]
5. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.
Ismail A; Khosravi H; Olson H
Heart Dis; 1999; 1(4):233-40. PubMed ID: 11720630
[TBL] [Abstract][Full Text] [Related]
6. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
Galle J
Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
[TBL] [Abstract][Full Text] [Related]
7. The role of inflammation in coronary artery calcification.
Li JJ; Zhu CG; Yu B; Liu YX; Yu MY
Ageing Res Rev; 2007 Dec; 6(4):263-70. PubMed ID: 17964226
[TBL] [Abstract][Full Text] [Related]
8. Inflammation in coronary artery disease: potential role for immunomodulatory therapy.
Aukrust P; Yndestad A; Waehre T; Gullestad L; Halvorsen B; Damås JK
Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1111-24. PubMed ID: 16293001
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of drugs targeting inflammation for the management of coronary artery disease.
Duchatelle V; Kritikou EA; Tardif JC
Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034
[TBL] [Abstract][Full Text] [Related]
10. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.
Dahl TB; Yndestad A; Skjelland M; Øie E; Dahl A; Michelsen A; Damås JK; Tunheim SH; Ueland T; Smith C; Bendz B; Tonstad S; Gullestad L; Frøland SS; Krohg-Sørensen K; Russell D; Aukrust P; Halvorsen B
Circulation; 2007 Feb; 115(8):972-80. PubMed ID: 17283255
[TBL] [Abstract][Full Text] [Related]
12. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
13. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
14. [Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome].
Fragoso-Lona JM; Ramírez-Bello J; Cruz-Robles D; Pérez-Méndez O; de la Peña A; Vargas-Alarcón G
Arch Cardiol Mex; 2009; 79(1):54-62. PubMed ID: 19545076
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of plaque instability.
Shah PK
Curr Opin Lipidol; 2007 Oct; 18(5):492-9. PubMed ID: 17885418
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in variant angina: is there any evidence?
Li JJ; Nie SP; Xu B; Guo YL; Gao Z; Zheng X
Med Hypotheses; 2007; 68(3):635-40. PubMed ID: 17030449
[TBL] [Abstract][Full Text] [Related]
17. Silent myocardial ischemia may be related to inflammatory response.
Li JJ
Med Hypotheses; 2004; 62(2):252-6. PubMed ID: 14962636
[TBL] [Abstract][Full Text] [Related]
18. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
[TBL] [Abstract][Full Text] [Related]
19. Identifying the vulnerable patient with rupture-prone plaque.
Weintraub HS
Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker.
Toth PP; McCullough PA; Wegner MS; Colley KJ
Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):425-38. PubMed ID: 20222820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
